TENS

Transcutaneous electrical nerve stimulation (TENS) delivers a low-voltage electrical current through electrodes placed on the skin, intended to stimulate underlying nerves and interrupt pain signaling — a mechanism often explained by "gate control theory" and the release of the body's own pain-modulating chemicals. TENS is one of the most widely researched non-drug pain therapies, with decades of trials across many conditions, including several Cochrane systematic reviews — generally considered a high bar for evidence quality.

For chronic pain, the evidence is genuinely uncertain. A 2019 Cochrane overview pooled findings from eight existing Cochrane reviews covering conditions like neuropathic pain, fibromyalgia, and neck pain. Its conclusion, in the authors' own words, was that the review team was unable to conclude with any confidence that TENS is harmful or beneficial for pain control, disability, quality of life, medicine use, or overall improvement in people with chronic pain — not because TENS doesn't work, but because the underlying trials were too small, inconsistent, or low-quality to say either way. Source: pmc.ncbi.nlm.nih.gov/articles/PMC6446021.

For acute, postoperative pain, results look more favorable. A 2023 systematic review and meta-analysis of 40 trials found that TENS was associated with lower pain scores at rest and during activity after surgery, along with reduced opioid use and fewer side effects like nausea and dizziness, compared to standard care. Source: pmc.ncbi.nlm.nih.gov/articles/PMC10816585.

Condition-specific reviews report mixed results depending on what's being treated: a 2023 meta-analysis on trigeminal neuralgia reported a significant benefit across a small number of included studies, while emergency-department and cardiothoracic-surgery reviews have found more inconsistent results depending on the outcome measured. Sources: ncbi.nlm.nih.gov/pmc/articles/PMC10306390; ncbi.nlm.nih.gov/pmc/articles/PMC11358505.

TENS is unusual among the modalities on this site in that it's been studied more, for longer, at higher evidence standards — and the result is still described by researchers as an "efficacy impasse." A 2021 narrative review drawing on three decades of TENS meta-analyses put it plainly: recent reviews, including Cochrane reviews, remain inconclusive or conflicting despite a constant stream of new trials, and clinical guidelines on whether to recommend TENS are inconsistent between countries and conditions. Source: ncbi.nlm.nih.gov/pmc/articles/PMC8070828.

This doesn't mean TENS doesn't work — it means the research to date hasn't settled the question either way for chronic pain specifically, even after a large volume of study.

None of the studies above were conducted on the Aura Matrix Elite. TENS trials use standardized, calibrated clinical TENS units at specific electrode placements, frequencies, and intensities for a defined pain condition — parameters that aren't established for a wellness-context session with a different device.

It's included here because it's the closest published, peer-reviewed research on TENS that we could locate — not because it demonstrates anything about this product's effects on any specific person.